COVID-19 Viral Load Rebound Can Occur After VV116, Nirmatrelvir-Ritonavir

WEDNESDAY, March 20, 2024 -- For patients with mild-to-moderate COVID-19, viral load rebound and symptom rebound can occur after a standard five-day course of treatment with VV116 or nirmatrelvir-ritonavir, according to a study published online...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news